Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Co-Diagnostics, Guardant Health, Scientia Vascular.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arc Medical Design, Anpac Bio-Medical Science, BBS-Bioactive Bone Substitutes, Bruker, Establishment Labs Holdings, Highmark, Mdxhealth, Norgine Orion Trading, Olympus, Sbl Technologies, Senseonics, Sparta, Todos Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Caption Health.

Med-tech firms raising money in public or private financings, including: Avinger, Innovheart, Quanterix.

New hires and promotions in the med-tech industry, including: Atricure, Cutera, Halberd, Florence Healthcare, Pacific Biosciences of California, Pulse Biosciences.

Biopharmas raising money in public or private financings, including: Arya, Biohaven, Checkmate, FSD, Freeline, Horizon.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bayer, Biogen, Canbridge, Cytodyn, Eisai, Intellia, Kazia, PTC, Roche, Viiv.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Allergan, Cancer Targeted Technology, Conifer, Editas, Ensysce, Ev, Eversana, Gilead, Immvira, Lodo, Moderna, Mucokinetica, Novavax, Nura, Pfizer, Shanghai Pharmaceuticals, Takeda, Yulong, Zosano.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Altimmune, Cstone, Everest, Ligand, Oncolys, Oncopeptides, Roche, Satsuma.

Quarterly snapshots from biopharma companies with marketed products, including: Adamas, Amag, Beigene, Clovis, Coherus, Exelixis, Dynavax, Fibrogen, GW, Ocular, Puma.